ERBB2 and breast cancer: To be of use as a delivery mechanism, it is necessary for the HER2-binding Affimers to be selectively internalized by HER2-positive breast cancer cell lines, as seen with other SBPs11,13,14,20,21 and antibody-drug conjugates such as trastuzumab emtansine.22